Practical Considerations for Managing Adverse Events with Tukysa (tucatinib): A Treatment Option for Patients with HER-2+ Metastatic Breast Cancer (MBC)
Speaker:
Melissa Rikal, NP
Tennessee Oncology/Sarah Cannon Research Institute
Date:
Thursday, January 6th
Registration: 530 pm
Program Start: 6 pm
Location:
Stoney River
3015 West End Ave
Nashville, TN 37203
